InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
PLX | Ann: Notice of issue of shares under employee share option plan | 21/03/19 | 0 | 40 | |||
|
|||||||
PLX | Ann: Plexure Group Limited at the Emerging Companies Conference | 14/03/19 | 0 | 212 | |||
|
|||||||
PLX | Ann: Plexure Group Limited (NZX:PLX) Market Update | 12/03/19 | 0 | 163 | |||
|
|||||||
PLX | Ann: SPH Notice - Scott Bradley, Rebecca Bradley, Sharbo ULC | 27/02/19 | 0 | 101 | |||
|
|||||||
PLX | Ann: SPH Notice - Scobie Ward | 26/02/19 | 0 | 106 | |||
|
|||||||
PLX | Ann: Plexure Group Limited – Share Buyback | 12/02/19 | 0 | 106 | |||
|
|||||||
PLX | Ann: Plexure Group Limited – Share Buyback | 11/02/19 | 0 | 126 | |||
|
|||||||
PLX | Ann: NZXR Share Price Enquiry into Plexure Group Limited | 09/01/19 | 0 | 190 | |||
|
See All Discussions